id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-348430-8xk4dt7t	Bragazzi, Nicola Luigi	COVID‐19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED‐ZONE declaration	2020-05-28		.txt	text/plain	1953	118	38	To the best of our knowledge, there is a dearth of data concerning the COVID-19 perceptions of dermatological patients under biologics, a therapy traditionally associated to an increased risk of infections. • in psoriatic patients: Psoriasis Area Severity Index (PASI) 14 ≥10 and or Disease Activity index for PSoriatic Arthritis" (DAPSA) 15 Remarkably, in these departments patients undergoing a biological therapy were affecting only by psoriasis (PsO), or atopic dermatitis (AD) or hidradenitis suppurativa (HS). Despite only 8.1% thought that biologics expose them to a moderate to severe risk to contract SARS-CoV2, 18.4% and 21.4% of the whole patients declared that they have assessed the possibility to discontinue or modify the dosage of the current biologic therapy, respectively. 29 In literature, both psoriasis, atopic dermatitis and hidradenitis suppurativa displayed an higher risk of respiratory comorbidities; in accord with this evidence 30% of the interviewed patients thought that their dermatological disease could increase the SARS-CoV2 infection risk.	./cache/cord-348430-8xk4dt7t.txt	./txt/cord-348430-8xk4dt7t.txt